Cargando…
Infection with equine infectious anemia virus vaccine strain EIAV(DLV121) causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response
The live equine infectious anemia virus (EIAV) vaccine strain EIAV(DLV121) was developed by in vitro attenuation of a virulent strain, EIAV(LN40), in the 1970s, and it has been demonstrated to induce protective immunity under laboratory and natural EIAV infection conditions. The detailed biological...
Autores principales: | Liu, Qiang, Ma, Jian, Wang, Xue-Feng, Xiao, Fei, Li, Li-Jia, Zhang, Jiao-Er, Lin, Yue-Zhi, Du, Cheng, He, Xi-Jun, Wang, Xiaojun, Zhou, Jian-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112881/ https://www.ncbi.nlm.nih.gov/pubmed/26832985 http://dx.doi.org/10.1016/j.vetimm.2016.01.006 |
Ejemplares similares
-
Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain
por: Ma, Jian, et al.
Publicado: (2014) -
Host cell restriction factors of equine infectious anemia virus
por: Wang, Xue-Feng, et al.
Publicado: (2023) -
The Soluble Form of the EIAV Receptor Encoded by an Alternative Splicing Variant Inhibits EIAV Infection of Target Cells
por: Lin, Yue-Zhi, et al.
Publicado: (2013) -
Genetic Evolution during the development of an attenuated EIAV vaccine
por: Wang, Xue-Feng, et al.
Publicado: (2016) -
ESCRT requirements for EIAV budding
por: Sandrin, Virginie, et al.
Publicado: (2013)